Human antimicrobial peptides HBD-3 and LL-37 were significantly elevated in infected joint replacement tissue and may serve as future biomarkers for faster PJI diagnosis.
LL-37 predicts prognosisPatients with positive LL-37 staining in joint tissue had worse outcomes at one year, suggesting this antimicrobial peptide could serve as both a diagnostic and prognostic marker
What the researchers found
Immunohistochemistry revealed significantly increased HBD-3 and LL-37 antimicrobial peptide levels in periprosthetic tissue from infected joint replacements versus aseptically loosened joints. Positive LL-37 staining was associated with a more reserved prognosis at one-year follow-up. Both peptides could serve as biomarkers for distinguishing septic from aseptic implant failure.
Why it matters
Misdiagnosing joint replacement infections leads to wrong treatment and poor outcomes. Current diagnostic methods are imperfect. Antimicrobial peptides measured directly in tissue could provide a faster, cheaper, and more accurate diagnostic tool — and LL-37 levels may also predict how well patients will do after treatment.
The numbers in context
Not specified in abstract.
How the study worked
Cohort study of 52 arthroplasty revision surgeries (septic and aseptic). Periprosthetic tissue analyzed by immunohistochemistry using anti-HBD-3 and anti-LL-37 antibodies. Staining intensity and percentage scored. One-year clinical outcomes compared between groups.
Who was studied
Arthroplasty patients with suspected periprosthetic joint infection
What this study cannot tell us
Small sample of 52 surgeries — needs larger validation. Immunohistochemistry requires tissue biopsy, limiting use as a pre-operative screening tool. Retrospective design. No comparison with existing diagnostic methods (CRP, ESR, synovial fluid analysis). Only one-year follow-up.
How to read the evidence
Rated preliminary: small cohort study of 52 surgeries. Promising biomarker discovery but needs larger prospective validation.
When this study was published
Published in 2024. Emerging application of antimicrobial peptide biology in orthopedic diagnostics.
The bigger picture
Antimicrobial peptides are part of the innate immune system's first response to infection. Using them as diagnostic biomarkers leverages the body's own infection-detection system — a natural peptide-based diagnostic approach.
Questions still open
- Could HBD-3 and LL-37 be measured in synovial fluid or blood as a less invasive test?
- How do antimicrobial peptide levels compare to existing PJI diagnostic criteria?
- Does LL-37 elevation predict specific types of infecting organisms?
Common questions
What are antimicrobial peptides?
How could peptides help diagnose joint infections?
Read the original research
Immunohistochemistry Study of Antimicrobial Peptides as a Future Diagnostic and Prognostic Tool for Periprosthetic Joint Infections.
Cureus, 16(9), e69629
Citation
Sandu, Emanuel-Cristian; Serban, Bogdan; Iordache, Sergiu; Cursaru, Adrian; Costache, Mihai Aurel; Dumitru, Adrian; Cirstoiu, Catalin. (2024). Immunohistochemistry Study of Antimicrobial Peptides as a Future Diagnostic and Prognostic Tool for Periprosthetic Joint Infections.. Cureus, 16(9), e69629. https://doi.org/10.7759/cureus.69629